Abstract

Polo-like kinase 1 (Plk1) is instrumental for mitotic entry and progression. Plk1 is activated by phosphorylation on a conserved residue Thr210 in its activation segment by the Aurora A kinase (AURKA), a reaction that critically requires the co-factor Bora phosphorylated by a CyclinA/B-Cdk1 kinase. Here we show that phospho-Bora is a direct activator of AURKA kinase activity. We localize the key determinants of phospho-Bora function to a 100 amino acid region encompassing two short Tpx2-like motifs and a phosphoSerine-Proline motif at Serine 112, through which Bora binds AURKA. The latter substitutes in trans for the Thr288 phospho-regulatory site of AURKA, which is essential for an active conformation of the kinase domain. We demonstrate the importance of these determinants for Bora function in mitotic entry both in Xenopus egg extracts and in human cells. Our findings unveil the activation mechanism of AURKA that is critical for mitotic entry.

Tavernier et al. decipher the mechanism by which the intrinsically disordered protein Bora, phosphorylated by Cyclin-Cdk, potentiates AURKA activity towards Polo-like kinase 1. Furthermore, they demonstrate the importance of this mechanism for timely mitotic entry in Xenopus and human cells.

Details

Title
Bora phosphorylation substitutes in trans for T-loop phosphorylation in Aurora A to promote mitotic entry
Author
Tavernier, N 1 ; Thomas, Y 2 ; Vigneron, S 3 ; Maisonneuve, P 4   VIAFID ORCID Logo  ; Orlicky, S 4 ; Mader, P 4 ; Regmi, S G 5 ; Van, Hove L 6 ; Levinson, N M 7   VIAFID ORCID Logo  ; Gasmi-Seabrook, G 8 ; Joly, N 9 ; Poteau, M 10 ; Velez-Aguilera, G 11 ; Gavet, O 10 ; Castro, A 3   VIAFID ORCID Logo  ; Dasso, M 5   VIAFID ORCID Logo  ; Lorca, T 3 ; Sicheri, F 12   VIAFID ORCID Logo  ; Pintard, L 13   VIAFID ORCID Logo 

 Centre for Systems Biology, Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, Canada (GRID:grid.250674.2) (ISNI:0000 0004 0626 6184); Programme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France (GRID:grid.250674.2) 
 Programme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France (GRID:grid.250674.2) 
 Centre de Recherche de Biologie cellulaire de Montpellier, UMR 5237, Université de Montpellier, CNRS, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141) 
 Centre for Systems Biology, Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, Canada (GRID:grid.250674.2) (ISNI:0000 0004 0626 6184) 
 Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, USA (GRID:grid.420089.7) (ISNI:0000 0000 9635 8082) 
 Programme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France (GRID:grid.420089.7) 
 University of Minnesota, Department of Pharmacology, Minneapolis, USA (GRID:grid.17635.36) (ISNI:0000000419368657) 
 Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (GRID:grid.415224.4) (ISNI:0000 0001 2150 066X) 
 Programme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France (GRID:grid.415224.4) 
10  Institut Gustave Roussy CNRS UMR9019, Villejuif, France (GRID:grid.14925.3b) (ISNI:0000 0001 2284 9388) 
11  Programme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France (GRID:grid.14925.3b) 
12  Centre for Systems Biology, Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, Canada (GRID:grid.250674.2) (ISNI:0000 0004 0626 6184); University of Toronto, Department of Molecular Genetics, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); University of Toronto, Department of Biochemistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
13  Programme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France (GRID:grid.17063.33) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2505573460
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.